Friday 6 November 2026 Export TWST’s income statement to Excel — free account

Twist Bioscience Corporation

Twist Bioscience Corporation’s revenue for fiscal 2025 (year ended September 2025) was $376.6 million, up 20.3% from fiscal 2024.

Revenue: +23.2%
EPS: −264.7%
Free cash flow: −7.23%
Total debt: 0.00%

Quarter to June 2026, against a year earlier

118.35 2.26 −1.87%

Follow TWST

Alert me

Market cap: $7.9B
P/E: 0.0×
Fwd P/E: −91.4×
Dividend yield: —
F-score: 4/9
Altman Z: 3.44
Beneish M: −2.30
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Twist Bioscience Corporation (TWST) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Twist Bioscience Corporation (TWST) trades at a P/S ratio of 17.6×. Over the past ten years it has ranged from 1.7× (November 2018) to 94.6× (January 2021); the current reading is higher than 68% of that period. That is above the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/TWST/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Twist Bioscience Corporation P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/TWST/metrics/ps-ratio">Twist Bioscience Corporation (TWST) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	4.5×	(46.64%)
FY2024	8.4×	88.24%
FY2023	4.4×	(52.31%)
FY2022	9.3×	(76.08%)
FY2021	39.0×	18.03%
FY2020	33.0×	174.04%
FY2019	12.1×	626.62%
FY2018	1.7×	0.00%
FY2017	1.7×	0.00%
FY2016	1.7×	—

Period	P/S ratio	Change
Jun 2026	14.9×	107.64%
Mar 2026	7.2×	44.71%
Dec 2025	4.9×	10.71%
Sep 2025	4.5×	(26.65%)
31 more quarters	Free account

Against its own ten years

Low 1.7× High 94.6×

Ten-year median 11.1×

Current reading's percentile 68

Company	P/S ratio
CAI Caris Life Sciences,�Inc. compare	7.1×
MDGL Madrigal Pharmaceuticals, Inc. compare	8.2×
TGTX TG Therapeutics, Inc. compare	10.3×
TWST Twist Bioscience Corporation	17.6×
KRYS Krystal Biotech, Inc. compare	18.9×
PTGX Protagonist Therapeutics, Inc. compare	31.7×
IBRX ImmunityBio, Inc. compare	51.0×
CYTK Cytokinetics, Incorporated compare	64.4×
SYRE Spyre Therapeutics, Inc. compare	8,160×
Biotechnology industry median	9.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Twist Bioscience Corporation (TWST) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on TWST

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on TWST

Stockrow Weekly